RecruitingNot Applicable

Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

United States425 participantsStarted 2021-03-10

Plain-language summary

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. English or Spanish-speaking
✓. 18 years of age and older
✓. Child discharged home with a Rx for \>1 daily liquid medication (other than multivitamin)
✓. Primary person who will administers child's medications.
✓. Willingness and ability to participate

Exclusion criteria

✕. Does not have a working phone number
✕. Does not have access to internet (via computer/smartphone)
✕. Does not have a mobile phone that receives texts.
✕. Not able to return to the hospital for their child's follow-up visit
✕. Visual acuity worse than 20/50 according to the Rosenbaum Pocket Screener
✕. Uncorrectable hearing impairment

What they're measuring

Improvement in Dosing with HELPix+TECH and HELPix in comparison to usual care.

Timeframe: Visit 3 (Day 30)

Improvement in medication adherence with HELPix+TECH and HELPix in comparison to usual care

Timeframe: Visit 3 (Day 30)

Trial details

NCT IDNCT04278690

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

Contact for this trial

Hsiang Shonna Yin

646-501-4284 hsiang.yin@nyulangone.org

View on ClinicalTrials.gov More Medication Administered in Error trials